北非的囊性纤维化疾病负担
Nada El Makhzen1, Houria Daimi2,3, Laila Bouguenouch4
1Ion Channels and Channelopathies Laboratory, Institute for Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland.
北非的囊性纤维化 (CF) 患病率可能被低估,因为诊断方面存在挑战. 需要更多的遗传和流行病学研究来改善非洲人群中CF诊断.
科学领域:
- 遗传学 是一个遗传学.
- 流行病学 流行病学
- 病变的发生和发病.
背景情况:
- 囊性纤维化 (CF) 是一种全球性自体衰退性疾病,由囊性纤维化跨膜导电性调节器 (CFTR) 基因中的200多种致病变体引起.
- 该p.Phe508del变异是最常见的CFTR突变.
- 最近的研究表明,CF的全球流行率高于此前的估计.
研究的目的:
- 审查CF的病变发生.
- 评估北非国家CF的流行率.
- 突出非洲人口中CF数据的信息差距.
主要方法:
- 关于CF病变发生的文献评论.
- 对北非CF现有的流行病学数据的分析.
- 讨论诊断挑战和遗传调查需求.
主要成果:
- 在非洲人群中,全面的CF数据很少,导致潜在的低估,特别是在儿童中.
- 北非的CF患病率可能被低估了.
- 疾病的复杂性和缺乏及时的遗传调查阻碍了CF的早期识别.
结论:
- 北非CF患者的早期鉴定受到诊断复杂性和遗传研究不足的限制.
- 对有症状的非洲人进行有针对性的遗传和流行病学研究至关重要.
- 提高非洲CF的诊断产量需要专门的研究努力.
更多相关视频
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
